The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of two dosing regimens of multiple, subcutaneous (sc) injections of ASP2408 in patients with Rheumatoid Arthritis (RA) on Methotrexate (MTX) and to evaluate the pharmacodynamics (PD) of ASP2408.

Read more: http://www.clinicaltrials.gov/ct2/show/NCT02052375?cond=%22Arthritis%22&lup_s=01/29/2014&lup_d=30